Trial intelligence / Profile preview

Zinc Supplementation in Pediatric Sepsis

NCT05366595Phase 2Completed

Sponsor
Mansoura University
Start
Jul 2019
Primary completion
Jun 2022
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, single-blind trial of zinc in sepsis (2 arms), sponsored by Mansoura University. Primary endpoint: Mortality rate at 1 year. Started Jul 2019; status: completed.

02

Drugs

zinc
03

Conditions

sepsis

Beyond the preview

Go deeper on NCT05366595.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05366595.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call